Ads
related to: immuno
Search results
MilliporeSigma Announces Siren Biotechnology As Winner Of Its North American Advance Biotech Grant
BioresearchOnline· 1 day agoScience business of Merck KGaA, Darmstadt, Germany, announced today that Siren Biotechnology has...
Affimed's AFM24 With Atezolizumab For EGFR Wild-Type NSCLC Gets FDA Fast Track Status; Stock Up
RTT News· 7 days agoAffimed N.V. (AFMD), a clinical-stage immuno-oncology company, Wednesday announced that it has received Fast Track Designation from the U.S. Food and Drug Administration for ...
Aptevo Participating in the BIO International Convention
Digital Journal· 2 days ago(Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform ...
Affimed (AFMD) Soars on Upbeat Follow-Up Data From NSCLC Study
Zacks via Yahoo Finance· 17 hours agoAffimed (AFMD) rallies 69% on positive follow-up efficacy data from its early to mid-stage study of...
... Agreement with Regeneron Pharmaceuticals to Evaluate FibroGen's Immuno-Oncology Assets, FG-3165...
Benzinga· 2 days agoFibroGen to evaluate FG-3165, an anti-galectin 9 (Gal9) monoclonal antibody (mAb), as monotherapy treatment as well as in combination with LIBTAYO® in patients with select solid tumorsFibroGen to evaluate FG-3175,
Medical Breakthroughs: 12-year-old girl overcoming chronic condition to continue figure skating
KRGV Rio Grande Valley· 4 days agoFigure skating is a hard sport. Athletes need strength, coordination and the ability to land on thin...
GSK’s Jemperli shows potential in Phase II trial for locally advanced rectal cancer
Clinical Trials Arena via Yahoo Finance· 24 hours agoJemperli is a programmed death receptor-1 (PD-1)-blocking antibody that is being assessed in various...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoNeoImmuneTech's New Data at ASCO 2024 Highlights Enhanced Benefits of Combining NT-I7 with Checkpoint Inhibitors (CPI) in Immuno-Oncology PR Newswire ROCKVILLE, Md., June ...
OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating...
Benzinga· 3 hours agoOSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant At the American Transplant Congress 2024 (June 1-5 Philadelphia) Nantes,
What is science? Tech heavyweights brawl over definition
Nature· 5 days agoAI pioneer Yann LeCun and Elon Musk went head-to-head in a debate about modern research that drew...